Cytonus' CEO, Remo Moomiaie-Qajar, MD, to unveil vast new platform of proprietary Cargocyte™ next-generation Adoptive Cellular Therapy (ACT) technologies. Its pipeline of products to treat cancers and inflammatory diseases creates the potential to improve the health and lives of millions across the globe
(PRWeb January 11, 2020)
Read the full story at https://www.prweb.com/releases/cytonus_therapeutics_ceo_to_present_at_biotech_showcase_in_san_francisco/prweb16829330.htm